Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry

Computers and Chemical Engineering

Volumn 47, Issue , 2012, Pages 19-28

  Lainez J M ^a   Schaefer, E ^b   Reklaitis, G V ^a  

^a PURDUE UNIVERSITY   (United States)

^b Janssen Family of Pharmaceutical Companies of Johnson and Johnson   (United States)

Author keywords

Capacity planning; New product development; Pharmaceuticals; Supply chain management

Indexed keywords

CAPACITY PLANNING; CHEMICAL PROCESS INDUSTRY; DECISION SUPPORT APPLICATIONS; ENTERPRISE-WIDE OPTIMIZATION; NEW PRODUCT DEVELOPMENT; PHARMACEUTICAL INDUSTRY; PIPELINE MANAGEMENT; PROCESS SYSTEMS ENGINEERING; RESEARCH EFFORTS;

CHEMICAL INDUSTRY; DRUG PRODUCTS; SUPPLY CHAIN MANAGEMENT;

PRODUCT DEVELOPMENT;

EID: 84869506991     PISSN: 00981354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compchemeng.2012.07.002     Document Type: Article

References (63)

1. Abdelkafi C., Beck B., David B., Druck C., Horoho M. Balancing risk and costs to optimize the clinical supply chain-A step beyond simulation. Journal of Pharmaceutical Innovation 2009, 4(3):96-106.
2. Amaro A., Barbosa-Póvoa A. Planning and scheduling of industrial supply chains with reverse flows: A real pharmaceutical case study. Computers & Chemical Engineering 2008, 32:2606-2625.
3. Blau G., Pekny J., Varma V., Bunch P. Managing a portfolio of interdependent new product candidates in the pharmaceutical industry. Journal of Product Innovation Management 2004, 21:227-245.
4. Chen Y., Mockus L., Orcun S., Reklaitis G.V. Simulation-based optimization approach to clinical trial supply chain management. Computer Aided Chemical Engineering 2010, 28:145-150.
5. Chen Y., Mockus L., Orcun S., Reklaitis G.V. Simulation-based optimization approach to clinical trial supply chain management with demand scenario forecast. Computers & Chemical Engineering 2012, 40:82-96.
6. Colvin M., Maravelias C. A stochastic programming approach for clinical trial planning in new drug development. Computers & Chemical Engineering 2008, 32:2626-2642.
7. Colvin M., Maravelias C. Scheduling of testing tasks and resource planning in new product development using stochastic programming. Computers & Chemical Engineering 2009, 33:964-976.
8. Colvin M., Maravelias C. R&D pipeline management: Task interdependencies and risk management. European Journal of Operational Research 2011, 215:616-628.
9. Dowlman N., Lang M., McEntegart D., Nicholls G., Bacon S., Star J., et al. Optimizing the supply chain through trial simulation. Applied Clinical Trials 2004, 13(7):40-46.
10. Fandel G., Stammen M. A general model for extended strategic supply chain management with emphasis on product life cycles including development and recycling. International Journal of Production Economics 2004, 89:293-308.
11. Fermier A., McKenzie P., McWeeney S., Murphy T., Schaefer E. Stopping Pharma's DRIP (Data-Rich/Information-Poor) problem: A standardized, recipe-based approach adds value and turns data into actionable knowledge. Pharmaceutical Manufacturing 2011, September, 20-26.
12. Fleischhacker A., Zhao Y. Planning for demand failure: A dynamic lot size model for clinical trial supply chains. European Journal of Operational Research 2011, 211:496-506.
13. Gatica G., Papageorgiou L., Shah L. Capacity planning under uncertainty for the pharmaceutical industry. Trans IChemE, Part A 2003, 81:665-678.
14. George E., Farid S. Stochastic combinatorial optimization approach to biopharmaceutical portfolio management. Industrial & Engineering Chemistry Research 2008, 47:8762-8774.
15. Grossmann I. Enterprise-wide optimization: A new frontier in process systems engineering. AIChE Journal 2005, 51:1846-1857.
16. Hailemariam L., Venkatasubramanian V. Purdue ontology for pharmaceutical engineering: Part I. Conceptual framework. Journal of Pharmaceutical Innovation 2010, 5(3):88-99.
17. Hailemariam L., Venkatasubramanian V. Purdue ontology for pharmaceutical engineering: Part II. Applications. Journal of Pharmaceutical Innovation 2010, 5(4):139-146.
18. Hunt V., Manson N., Morgan P. A wake up call for Big Pharma. Lower profit margins suggest a need for new business models. McKinsey Quarterly 2011, December.
19. Jain V., Grossmann I. Resource-constrained scheduling of tests in new product development. Industrial & Engineering Chemistry Research 1999, 38:3013-3026.
20. Junker B., Maheshwari G., Ranheim T., Altaras N., Stankevicz M., Harmon L., et al. Design-for-six-sigma to develop a bioprocess knowledge management framework. PDA Journal of Pharmaceutical Science and Technology 2011, 65:140-165.
21. IMS Institute. (2011, May). The global use of medicines: Outlook through 2015. Technical report.
22. Kimko H.C., Duffull S.B. Simulation for designing clinical trials 2003, Marcel Dekker, New York.
23. Laínez J.M., Kopanos G., Espuña A., Puigjaner L. Flexible design-planning of supply chain networks. AIChE Journal 2009, 55(7):1736-1753.
24. Laínez J.M., Reklaitis G.V., Puigjaner L. Financial and financial engineering considerations in supply chain and product development pipeline management. Computers & Chemical Engineering 2009, 33:1999-2011.
25. Laínez J.M., Reklaitis G.V., Puigjaner L. Linking marketing and supply chain models for improved business strategic decision support. Computers & Chemical Engineering 2010, 34:2107-2117.
26. Levis A., Papageorgiou L. A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry. Computers & Chemical Engineering 2004, 28:707-725.
27. Maravelias C., Grossmann I. Simultaneous planning for new product development and batch manufacturing facilities. Industrial & Engineering Chemistry Research 2001, 40:6147-6164.
28. Maravelias C., Grossmann I. Optimal resource investment and scheduling of tests for new product development. Computers & Chemical Engineering 2004, 28:1021-1038.
29. McGarvey B.M., Dynes N.J., Lin B.C., Anderson W.H., Kremidas J.P., Felli J.C. A discrete event model of clinical trial enrollment at Eli Lilly and company. Proceedings of the 39th conference on Winter simulation: 40 years! The best is yet to come 2007, 1467-1474. IEEE Press, Washington, DC.
30. Miller D., Schertz D., Stevens C., Pekny J. Mathematical programming for the design and analysis of a biologics facility. Part 1. BioPharm International 2010, February, 26-38.
31. Miller D., Schertz D., Stevens C., Pekny J. Mathematical programming for the design and analysis of a biologics facility. Part 2. BioPharm International 2010, March, 40-52.
32. Morbach J., Yang A., Marquardt W. Ontocape: A large-scale ontology for chemical process engineering. Engineering Applications of Artificial Intelligence 2007, 20:147-161.
33. Morbach J., Wiesner A., Marquardt W. Ontocape 2.0: A (re)usable ontology for computer-aided process engineering. Computers & Chemical Engineering 2009, 33:1546-1556.
34. Muñoz E., Espuña A., Puigjaner L. Towards an ontological infrastructure for chemical batch process management. Computers & Chemical Engineering 2010, 34(5):668-682.
35. Muñoz E., Capón-García E., Moreno-Benito M., Espuña A., Puigjaner L. Scheduling and control decision-making under an integrated information environment. Computers & Chemical Engineering 2011, 35(5):774-786.
36. Muñoz E., Capón-García E., Laínez J.M., Espuña A., Puigjaner L. Ontological framework for the enterprise from a process perspective. International conference on knowledge discovery and information retrieval (KDIR 2011) 2011, 538-546.
37. Pantelides C. Unified frameworks for optimal process planning and scheduling. Proceedings of the second international conference on foundations of computer-aided process operations 1994, 253-274. CACHE Publications, New York. D.W.T. Ripping, J.C. Hale, J. Davis (Eds.).
38. Papageorgiou L., Rotstein G., Shah N. Strategic supply chain optimization for the pharmaceutical industries. Industrial & Engineering Chemistry Research 2001, 40:275-286.
39. Pekny J., Reklaitis G.V. Towards the convergence of theory and practice: A technology guide for scheduling/planning methodology. Proceedings of the Foundations of computer-aided process operations 1998, 91-111.
40. Pérez-Escobedo J.L., Azzaro-Pantel C., Pibouleau L. New product development with discrete event simulation: Application to portfolio management for the pharmaceutical industry. Industrial & Engineering Chemistry Research 2011, 50:10615-10629.
41. Peterson M., Byrom B., Dowlman N., McEntegart D. Optimizing clinical trial supply requirements: Simulation of computer-controlled supply chain management. Clinical Trials 2004, 1(4):399-412.
42. PhRMA Pharmaceutical industry profile 2007, Pharmaceutical Research and Manufacturers of America, Washington, DC.
43. Porter M.E. Competitive strategy 1980, The Free Press, New York, NY.
44. Puigjaner L., Guillén-Golsálbez G. Towards and integrated framework for supply chain management in the batch chemical industry. Computers & Chemical Engineering 2008, 32:650-670.
45. Rogers M.J., Gupta A., Maranas C.D. Real options based analysis of optimal pharmaceutical research and development portfolios. Industrial & Engineering Chemistry Research 2002, 41:6607-6620.
46. Rotstein G., Shah N., Sorensen E., Macchietto S., Weiss R. Analysis and design of paint manufacturing processes. Computers & Chemical Engineering 1998, 22:S279-S282.
47. Schmidt C., Grossmann I. Optimization models for the scheduling of testing tasks in new product development. Industrial & Engineering Chemistry Research 1996, 35:3498-3510.
48. Schmidt C., Grossmann I., Blau G. Optimization of industrial scale scheduling problems in new product development. Computers & Chemical Engineering 1998, 22:S1027-S1030.
49. Sesen M., Suresh P., Banares-Alcantara R., Venkatasubramanian V. An ontological framework for automated regulatory compliance in pharmaceutical manufacturing. Computers &Chemical Engineering 2010, 34:1155-1169.
50. Shah N. Process industry supply chains: Advances and challenges. Computers & Chemical Engineering 2005, 29:1225-1236.
51. Shapiro J. Challenges of strategic supply chain planning and modeling. Computers & Chemical Engineering 2004, 28:855-861.
52. Sousa R., Liu S., Papageorgiou L., Shah N. Global supply chain planning for pharmaceuticals. Chemical Engineering Research and Design 2011, 89:2396-2409.
53. Subramanian D., Pekny J., Reklaitis G. Simulation-optimization framework for research and development pipeline management. AIChE Journal 2001, 47:2226-2242.
54. Subramanian D., Pekny J., Reklaitis G., Blau G. Simulation-optimization framework for stochastic optimization of R&D pipeline management. AIChE Journal 2003, 49:96-112.
55. Sundaramoorthy A., Karimi A. Planning in pharmaceutical supply chain with outsourcing and new products introductions. Industrial & Engineering Chemistry Research 2008, 43:8293-8306.
56. Tollman P., Morieux Y., Murphy J., Schulze U. Can R&D be fixed? Lessons from Biopharma outliers 2011, The Boston Consulting Group.
57. Tsang K., Samsatli N., Shah N. Capacity investment planning for multiple vaccines under uncertainty. 1: Capacity planning. Food and Bioproducts Processing 2007, 85:120-128.
58. Tsang K., Samsatli N., Shah N. Capacity investment planning for multiple vaccines under uncertainty. 2: Financial risk analysis. Food and Bioproducts Processing 2007, 85:129-140.
59. Varma V., Reklaitis G.V., Blau G., Pekny J. Enterprise-wide modeling & optimization-An overview of emerging research challenges and opportunities. Computers & Chemical Engineering 2007, 31:692-711.
60. Venkatasubramanian V., Zhao C., Joglekar G., Jain A., Hailemariam L., Suresh P., et al. Ontological informatics infrastructure for pharmaceutical product development and manufacturing. Computers & Chemical Engineering 2006, 30:1482-1496.
61. Zapata J.C., Reklaitis G.V. Valuation of project portfolios: An endogenously discounted method. European Journal of Operational Research 2010, 206:653-666.
62. Zapata J.C., Varma V., Reklaitis G.V. Impact of tactical and operational policies in selection of a new product portfolio. Computers & Chemical Engineering 2008, 31:692-711.
63. Zapata J.C., Pekny J., Reklaitis G.V. Simulation-optimization in support of tactical and strategic enterprise decisions. Planning production and inventories in the extended enterprise 2011, 593-627. Springer, US. K.G. Kempf, P. Keskinocak, R. Uzsoy (Eds.).